An outlook on potential protein targets of COVID-19 as a druggable site
Article
[키워드] approved
cause
claimed
clinical trial
combating
contagious
COVID-19
COVID-19 disease
Cryo-electron microscopy
Delta
Efficacy
feature
genomic
help
host cell
host protein
infecting
inhibit
mechanism of action
MERS-CoV
Mutation
non-structural proteins
omicron
pandemic
Protein
Protein target
proteolytic cleavage
raised
Repurposed drug
required
SARS-CoV
SARS-CoV-2
SARS-CoV-2 entry
SARS-CoV-2 protein
shown
similarity
spike
Spike protein
strain
suggested
the vaccine
therapeutic drugs
therapeutic interventions
Vaccines
variants of SARS-CoV-2
viral infection
virus
Wuhan
X-ray diffraction
[DOI] 10.1007/s11033-022-07724-3 PMC 바로가기
[DOI] 10.1007/s11033-022-07724-3 PMC 바로가기